- Home
- ARMP vs PHUN Comparison
ARMP vs PHUN Comparison
Compare ARMP & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- PHUN
- Stock Information
- Founded
- ARMP N/A
- PHUN 2009
- Country
- ARMP United States
- PHUN United States
- Employees
- ARMP N/A
- PHUN N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- PHUN EDP Services
- Sector
- ARMP Health Care
- PHUN Technology
- Exchange
- ARMP Nasdaq
- PHUN Nasdaq
- Market Cap
- ARMP 52.1M
- PHUN 58.3M
- IPO Year
- ARMP N/A
- PHUN N/A
- Fundamental
- Price
- ARMP $1.95
- PHUN $2.97
- Analyst Decision
- ARMP Strong Buy
- PHUN Buy
- Analyst Count
- ARMP 1
- PHUN 2
- Target Price
- ARMP $9.00
- PHUN $7.50
- AVG Volume (30 Days)
- ARMP 624.1K
- PHUN 192.4K
- Earning Date
- ARMP 05-14-2025
- PHUN 05-12-2025
- Dividend Yield
- ARMP N/A
- PHUN N/A
- EPS Growth
- ARMP N/A
- PHUN N/A
- EPS
- ARMP N/A
- PHUN N/A
- Revenue
- ARMP $4,699,000.00
- PHUN $2,956,000.00
- Revenue This Year
- ARMP $8.43
- PHUN $10.47
- Revenue Next Year
- ARMP N/A
- PHUN $53.56
- P/E Ratio
- ARMP N/A
- PHUN N/A
- Revenue Growth
- ARMP 14.24
- PHUN N/A
- 52 Week Low
- ARMP $0.90
- PHUN $2.22
- 52 Week High
- ARMP $3.42
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- ARMP 56.79
- PHUN 48.94
- Support Level
- ARMP $1.74
- PHUN $2.86
- Resistance Level
- ARMP $2.20
- PHUN $3.18
- Average True Range (ATR)
- ARMP 0.32
- PHUN 0.14
- MACD
- ARMP 0.04
- PHUN -0.01
- Stochastic Oscillator
- ARMP 50.32
- PHUN 34.13
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.